ID   P2Y12_RAT               Reviewed;         343 AA.
AC   Q9EPX4;
DT   27-MAY-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 1.
DT   24-JUL-2024, entry version 153.
DE   RecName: Full=P2Y purinoceptor 12;
DE            Short=P2Y12;
DE   AltName: Full=P2Y12 platelet ADP receptor;
GN   Name=P2ry12; Synonyms=P2y12;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND SUBCELLULAR LOCATION.
RC   STRAIN=Sprague-Dawley;
RX   PubMed=11196645; DOI=10.1038/35051599;
RA   Hollopeter G., Jantzen H.-M., Vincent D., Li G., England L.,
RA   Ramakrishnan V., Yang R.-B., Nurden P., Nurden A., Julius D.J.,
RA   Conley P.B.;
RT   "Identification of the platelet ADP receptor targeted by antithrombotic
RT   drugs.";
RL   Nature 409:202-207(2001).
RN   [2]
RP   PROTEIN SEQUENCE OF 129-137, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   STRAIN=Sprague-Dawley; TISSUE=Brain;
RA   Lubec G., Kang S.U.;
RL   Submitted (JUL-2007) to UniProtKB.
RN   [3]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-61 AND SER-63, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=16641100; DOI=10.1073/pnas.0600895103;
RA   Hoffert J.D., Pisitkun T., Wang G., Shen R.-F., Knepper M.A.;
RT   "Quantitative phosphoproteomics of vasopressin-sensitive renal cells:
RT   regulation of aquaporin-2 phosphorylation at two sites.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:7159-7164(2006).
CC   -!- FUNCTION: Receptor for ADP and ATP coupled to G-proteins that inhibit
CC       the adenylyl cyclase second messenger system. Required for normal
CC       platelet aggregation and blood coagulation.
CC       {ECO:0000269|PubMed:11196645}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:11196645};
CC       Multi-pass membrane protein {ECO:0000269|PubMed:11196645}.
CC   -!- DOMAIN: The transmembrane domain is composed of seven transmembrane
CC       helices; most of these are not strictly perpendicular to the plane of
CC       the membrane, but are tilted and/or kinked. Agonist binding promotes a
CC       conformation change in the extracellular loops that leads to an inward
CC       movement of the transmembrane helices. Antagonists can bind to an
CC       overlapping site, but block the inward movement of the transmembrane
CC       helices (By similarity). {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the G-protein coupled receptor 1 family.
CC       {ECO:0000255|PROSITE-ProRule:PRU00521}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF313450; AAG48945.1; -; mRNA.
DR   RefSeq; NP_073637.1; NM_022800.1.
DR   RefSeq; XP_006232468.1; XM_006232406.3.
DR   RefSeq; XP_006232469.1; XM_006232407.3.
DR   RefSeq; XP_006232470.1; XM_006232408.3.
DR   AlphaFoldDB; Q9EPX4; -.
DR   SMR; Q9EPX4; -.
DR   BioGRID; 249199; 1.
DR   STRING; 10116.ENSRNOP00000018600; -.
DR   BindingDB; Q9EPX4; -.
DR   ChEMBL; CHEMBL2188; -.
DR   DrugCentral; Q9EPX4; -.
DR   GlyCosmos; Q9EPX4; 2 sites, No reported glycans.
DR   GlyGen; Q9EPX4; 2 sites.
DR   iPTMnet; Q9EPX4; -.
DR   PhosphoSitePlus; Q9EPX4; -.
DR   PaxDb; 10116-ENSRNOP00000018600; -.
DR   Ensembl; ENSRNOT00000018600.5; ENSRNOP00000018600.2; ENSRNOG00000013902.5.
DR   Ensembl; ENSRNOT00000116463.1; ENSRNOP00000086953.1; ENSRNOG00000013902.5.
DR   Ensembl; ENSRNOT00055031962; ENSRNOP00055025859; ENSRNOG00055018749.
DR   Ensembl; ENSRNOT00055031968; ENSRNOP00055025864; ENSRNOG00055018749.
DR   Ensembl; ENSRNOT00060008399; ENSRNOP00060006290; ENSRNOG00060005045.
DR   Ensembl; ENSRNOT00060008402; ENSRNOP00060006293; ENSRNOG00060005045.
DR   Ensembl; ENSRNOT00065042232; ENSRNOP00065034536; ENSRNOG00065024609.
DR   Ensembl; ENSRNOT00065042243; ENSRNOP00065034551; ENSRNOG00065024609.
DR   GeneID; 64803; -.
DR   KEGG; rno:64803; -.
DR   UCSC; RGD:621681; rat.
DR   AGR; RGD:621681; -.
DR   CTD; 64805; -.
DR   RGD; 621681; P2ry12.
DR   eggNOG; ENOG502QUS2; Eukaryota.
DR   GeneTree; ENSGT01110000267167; -.
DR   HOGENOM; CLU_009579_8_2_1; -.
DR   InParanoid; Q9EPX4; -.
DR   OrthoDB; 470522at2759; -.
DR   PhylomeDB; Q9EPX4; -.
DR   TreeFam; TF330969; -.
DR   Reactome; R-RNO-392170; ADP signalling through P2Y purinoceptor 12.
DR   Reactome; R-RNO-417957; P2Y receptors.
DR   Reactome; R-RNO-418594; G alpha (i) signalling events.
DR   PRO; PR:Q9EPX4; -.
DR   Proteomes; UP000002494; Chromosome 2.
DR   Bgee; ENSRNOG00000013902; Expressed in frontal cortex and 18 other cell types or tissues.
DR   GO; GO:0009925; C:basal plasma membrane; IDA:RGD.
DR   GO; GO:0005901; C:caveola; IDA:RGD.
DR   GO; GO:0044298; C:cell body membrane; ISO:RGD.
DR   GO; GO:0031253; C:cell projection membrane; ISO:RGD.
DR   GO; GO:0009897; C:external side of plasma membrane; IDA:RGD.
DR   GO; GO:0016020; C:membrane; ISS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0001609; F:G protein-coupled adenosine receptor activity; ISO:RGD.
DR   GO; GO:0001621; F:G protein-coupled ADP receptor activity; IDA:RGD.
DR   GO; GO:0045028; F:G protein-coupled purinergic nucleotide receptor activity; IBA:GO_Central.
DR   GO; GO:0007193; P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; ISS:UniProtKB.
DR   GO; GO:0007188; P:adenylate cyclase-modulating G protein-coupled receptor signaling pathway; ISO:RGD.
DR   GO; GO:0070588; P:calcium ion transmembrane transport; IDA:RGD.
DR   GO; GO:0019722; P:calcium-mediated signaling; IMP:ARUK-UCL.
DR   GO; GO:0030030; P:cell projection organization; IMP:RGD.
DR   GO; GO:0071318; P:cellular response to ATP; IMP:ARUK-UCL.
DR   GO; GO:0071407; P:cellular response to organic cyclic compound; ISO:RGD.
DR   GO; GO:0021801; P:cerebral cortex radial glia-guided migration; IMP:ARUK-UCL.
DR   GO; GO:0051649; P:establishment of localization in cell; ISO:RGD.
DR   GO; GO:0001973; P:G protein-coupled adenosine receptor signaling pathway; IMP:RGD.
DR   GO; GO:0007186; P:G protein-coupled receptor signaling pathway; IMP:RGD.
DR   GO; GO:0008347; P:glial cell migration; IMP:RGD.
DR   GO; GO:0030032; P:lamellipodium assembly; IMP:ARUK-UCL.
DR   GO; GO:0006811; P:monoatomic ion transport; ISO:RGD.
DR   GO; GO:0045596; P:negative regulation of cell differentiation; IMP:RGD.
DR   GO; GO:0010700; P:negative regulation of norepinephrine secretion; IMP:RGD.
DR   GO; GO:0007200; P:phospholipase C-activating G protein-coupled receptor signaling pathway; IMP:ARUK-UCL.
DR   GO; GO:0030168; P:platelet activation; ISO:RGD.
DR   GO; GO:0070527; P:platelet aggregation; ISO:RGD.
DR   GO; GO:0033630; P:positive regulation of cell adhesion mediated by integrin; IGI:ARUK-UCL.
DR   GO; GO:0050921; P:positive regulation of chemotaxis; IMP:ARUK-UCL.
DR   GO; GO:0033626; P:positive regulation of integrin activation by cell surface receptor linked signal transduction; IDA:ARUK-UCL.
DR   GO; GO:1904141; P:positive regulation of microglial cell migration; IMP:ARUK-UCL.
DR   GO; GO:0043270; P:positive regulation of monoatomic ion transport; ISO:RGD.
DR   GO; GO:0051897; P:positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction; IMP:ARUK-UCL.
DR   GO; GO:1900029; P:positive regulation of ruffle assembly; IMP:ARUK-UCL.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; IDA:RGD.
DR   GO; GO:0051924; P:regulation of calcium ion transport; IMP:RGD.
DR   GO; GO:0050920; P:regulation of chemotaxis; IMP:ARUK-UCL.
DR   GO; GO:1904139; P:regulation of microglial cell migration; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0048678; P:response to axon injury; IDA:ARUK-UCL.
DR   GO; GO:0006930; P:substrate-dependent cell migration, cell extension; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0150063; P:visual system development; ISO:RGD.
DR   CDD; cd15150; 7tmA_P2Y12; 1.
DR   Gene3D; 1.20.1070.10; Rhodopsin 7-helix transmembrane proteins; 1.
DR   InterPro; IPR000276; GPCR_Rhodpsn.
DR   InterPro; IPR017452; GPCR_Rhodpsn_7TM.
DR   InterPro; IPR005394; P2Y12_rcpt.
DR   PANTHER; PTHR24233:SF0; P2Y PURINOCEPTOR 12; 1.
DR   PANTHER; PTHR24233; P2Y PURINOCEPTOR-RELATED G-PROTEIN COUPLED RECEPTOR; 1.
DR   Pfam; PF00001; 7tm_1; 1.
DR   PRINTS; PR00237; GPCRRHODOPSN.
DR   PRINTS; PR01569; P2Y12PRNCPTR.
DR   PRINTS; PR01157; P2YPURNOCPTR.
DR   SUPFAM; SSF81321; Family A G protein-coupled receptor-like; 1.
DR   PROSITE; PS50262; G_PROTEIN_RECEP_F1_2; 1.
PE   1: Evidence at protein level;
KW   Blood coagulation; Cell membrane; Direct protein sequencing;
KW   Disulfide bond; G-protein coupled receptor; Glycoprotein; Hemostasis;
KW   Membrane; Phosphoprotein; Receptor; Reference proteome; Transducer;
KW   Transmembrane; Transmembrane helix.
FT   CHAIN           1..343
FT                   /note="P2Y purinoceptor 12"
FT                   /id="PRO_0000070039"
FT   TOPO_DOM        1..33
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        34..56
FT                   /note="Helical; Name=1"
FT                   /evidence="ECO:0000250"
FT   TOPO_DOM        57..67
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        68..88
FT                   /note="Helical; Name=2"
FT                   /evidence="ECO:0000250"
FT   TOPO_DOM        89..103
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        104..124
FT                   /note="Helical; Name=3"
FT                   /evidence="ECO:0000250"
FT   TOPO_DOM        125..148
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        149..168
FT                   /note="Helical; Name=4"
FT                   /evidence="ECO:0000250"
FT   TOPO_DOM        169..191
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        192..213
FT                   /note="Helical; Name=5"
FT                   /evidence="ECO:0000250"
FT   TOPO_DOM        214..239
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        240..265
FT                   /note="Helical; Name=6"
FT                   /evidence="ECO:0000250"
FT   TOPO_DOM        266..284
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        285..304
FT                   /note="Helical; Name=7"
FT                   /evidence="ECO:0000250"
FT   TOPO_DOM        305..343
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250"
FT   REGION          324..343
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         99
FT                   /ligand="ADP"
FT                   /ligand_id="ChEBI:CHEBI:456216"
FT                   /evidence="ECO:0000250"
FT   BINDING         103
FT                   /ligand="ADP"
FT                   /ligand_id="ChEBI:CHEBI:456216"
FT                   /evidence="ECO:0000250"
FT   BINDING         111
FT                   /ligand="ADP"
FT                   /ligand_id="ChEBI:CHEBI:456216"
FT                   /evidence="ECO:0000250"
FT   BINDING         162..165
FT                   /ligand="ADP"
FT                   /ligand_id="ChEBI:CHEBI:456216"
FT                   /evidence="ECO:0000250"
FT   BINDING         181..185
FT                   /ligand="ADP"
FT                   /ligand_id="ChEBI:CHEBI:456216"
FT                   /evidence="ECO:0000250"
FT   BINDING         193
FT                   /ligand="ADP"
FT                   /ligand_id="ChEBI:CHEBI:456216"
FT                   /evidence="ECO:0000250"
FT   BINDING         197
FT                   /ligand="ADP"
FT                   /ligand_id="ChEBI:CHEBI:456216"
FT                   /evidence="ECO:0000250"
FT   BINDING         262..265
FT                   /ligand="ADP"
FT                   /ligand_id="ChEBI:CHEBI:456216"
FT                   /evidence="ECO:0000250"
FT   BINDING         269
FT                   /ligand="ADP"
FT                   /ligand_id="ChEBI:CHEBI:456216"
FT                   /evidence="ECO:0000250"
FT   BINDING         286
FT                   /ligand="ADP"
FT                   /ligand_id="ChEBI:CHEBI:456216"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         61
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:16641100"
FT   MOD_RES         63
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:16641100"
FT   CARBOHYD        7
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        12
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        23..276
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00521"
FT   DISULFID        103..181
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00521"
SQ   SEQUENCE   343 AA;  39047 MW;  7AE0AFCE66674136 CRC64;
     MEVPGANATS ANTTSIPGTS TLCSRDYKIT QVLFPLLYTV LFFAGLITNS LAMRIFFQIR
     SKSNFIIFLK NTVISDLLMI LTFPFKILSD AKLGAGHLRT LVCQVTSVTF YFTMYISISF
     LGLITIDRYL KTTRPFKTSS PSNLLGAKIL SVAIWAFMFL LSLPNMILTN RRPKDKDITK
     CSFLKSEFGL VWHEIVNYIC QVIFWINFLI VIVCYSLITK ELYRSYVRTR GSAKAPKKRV
     NIKVFIIIAV FFICFVPFHF ARIPYTLSQT RAVFDCNAEN TLFYVKESTL WLTSLNACLD
     PFIYFFLCKS FRNSLMSMLR CSTSGANKKK GQEGGDPSEE TPM
//
